Description
Nebivol-5 Tablet is a prescription medicine containing Nebivolol 5mg, a cardioselective beta-blocker. It is commonly prescribed to manage hypertension (high blood pressure) and may also be used in certain patients with heart failure or other cardiovascular conditions as advised by a doctor.
Nebivolol lowers blood pressure by slowing the heart rate and relaxing blood vessels, allowing the heart to pump blood more efficiently.
Uses of Nebivol-5 Tablet
- High blood pressure (Hypertension)
- Chronic heart failure (in selected patients)
- Prevention of cardiovascular complications associated with hypertension
Benefits of Nebivol-5 Tablet
- Effectively lowers blood pressure
- Reduces strain on the heart
- Helps prevent heart attack and stroke
- Improves heart function in suitable patients
- Supports long-term cardiovascular health
How Nebivol-5 Tablet Works
Nebivolol blocks beta-1 receptors in the heart, slowing the heart rate and reducing the force of contraction. It also promotes relaxation of blood vessels through nitric oxide release, improving blood flow and lowering blood pressure.
Dosage
- Take Nebivol-5 Tablet exactly as prescribed by your doctor.
- It is usually taken once daily.
- Do not stop taking the medicine suddenly without consulting your doctor.
How to Use
- Swallow the tablet whole with a glass of water.
- It may be taken with or without food.
- Take it at the same time each day for the best results.
Side Effects
Common side effects include:
- Dizziness
- Headache
- Slow heart rate
- Fatigue
- Nausea
- Shortness of breath
- Cold hands and feet
Seek immediate medical attention if you experience severe dizziness, fainting, difficulty breathing, or an unusually slow heartbeat.
Precautions
- Inform your doctor if you have asthma, COPD, diabetes, liver disease, kidney disease, or a slow heart rate.
- Do not stop this medicine abruptly, as it may worsen heart conditions.
- Use cautiously during pregnancy and breastfeeding only if prescribed.
- Monitor blood pressure and heart rate regularly.







Leave a Reply